Arvinas, Inc. (ARVN)
8.78
-0.30
(-3.30%)
USD |
NASDAQ |
May 18, 16:00
8.74
-0.04
(-0.46%)
After-Hours: 05:19
Arvinas Free Cash Flow : -256.90M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 9.484B |
| Rigel Pharmaceuticals, Inc. | 79.27M |
| EyePoint, Inc. | -271.54M |
| Elanco Animal Health, Inc. | 315.00M |
| Corcept Therapeutics, Inc. | 119.79M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -69.20M |
| Cash from Investing (Quarterly) | 13.70M |
| Cash from Financing (Quarterly) | -0.10M |
| Free Cash Flow Per Share (Quarterly) | -1.102 |
| Free Cash Flow to Equity (Quarterly) | -70.00M |
| Free Cash Flow to Firm (Quarterly) | -70.50M |
| Free Cash Flow Yield | -42.54% |